Unusual early symptoms of Parkinson’s disease. Why do we need to identify them?
- Weitere Titel
-
Sintomas incomuns da fase inicial da doença de Parkinson. Por que precisamos identificá-los?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Unusual early symptoms of Parkinson’s disease. Why do we need to identify them? ; volume:74 ; number:10 ; year:2016 ; pages:779-780
Arquivos de neuro-psiquiatria ; 74, Heft 10 (2016), 779-780
- Beteiligte Personen und Organisationen
-
Ferraz, Henrique Ballalai
Silva, Carolina Candeias da
- DOI
-
10.1590/0004-282X20160135
- URN
-
urn:nbn:de:101:1-2023101912410405095659
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ferraz, Henrique Ballalai
- Silva, Carolina Candeias da
Ähnliche Objekte (12)
Gut microbiota helps identify clinical subtypes of Parkinson’s disease
Parkinson’s disease-associated protein Parkin: an unusual player in cancer
Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset
Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson’s disease
Unusual motor and non-motor symptoms and signs in the early stage of Parkinson’s disease
Parkinson
Parkinson
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Gut microbiota helps identify clinical subtypes of Parkinson’s disease
Parkinson’s disease-associated protein Parkin: an unusual player in cancer
Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset
Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson’s disease
Unusual motor and non-motor symptoms and signs in the early stage of Parkinson’s disease
Parkinson
Parkinson
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Gut microbiota helps identify clinical subtypes of Parkinson’s disease
Parkinson’s disease-associated protein Parkin: an unusual player in cancer
Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammation
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset
Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson’s disease
Unusual motor and non-motor symptoms and signs in the early stage of Parkinson’s disease
Parkinson
Parkinson
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease